title: Dangerous and common drug interactions in patients with diabetes mellitus.
abstract: As more medications are made available to the prescriber, the likelihood of drug interactions will increase. The number of drug interactions encountered by the provider treating the patient with diabetes has increased over the past few years because the number of medications used in the management of hyperglycemia has dramatically increased during that time. These interactions are complex but can be predicted.
authors.affiliation: Drug Studies Unit, College of Pharmacy, Washington State University, Spokane, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: White
authors.forename: R K
authors.initials: RK
authors.lastname: Campbell
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001786:Blood Glucose / Q000378:metabolism; D065607:Cytochrome P-450 Enzyme Inhibitors; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects; D000431:Ethanol / Q000009:adverse effects; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D007328:Insulin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D013566:Sympathomimetics / Q000009:adverse effects
chemical_list: D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D065607:Cytochrome P-450 Enzyme Inhibitors; D004232:Diuretics; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D013566:Sympathomimetics; D000431:Ethanol